Ureteral Cancer Withdrawn Phase 2 Trials for DB00441 (Gemcitabine)

Also known as: Ureter Cancer / Ureteric cancer / Ureteric cancer NOS / Cancer of Ureter / Ureter Ca / Malignant neoplasm of ureter

IndicationStatusPhase
DBCOND0034092 (Ureteral Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01639521Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerTreatment